Pages that link to "Q33666002"
Jump to navigation
Jump to search
The following pages link to Use of nonhuman primate models to develop mucosal AIDS vaccines (Q33666002):
Displaying 12 items.
- Some vexations that challenge viral immunology (Q24672537) (← links)
- Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions (Q27320923) (← links)
- New directions for HIV vaccine development from animal models (Q33767191) (← links)
- Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model (Q33862010) (← links)
- Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development (Q34480617) (← links)
- Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V. (Q35153426) (← links)
- Characterization of an effective CTL response against HIV and SIV infections (Q35250925) (← links)
- Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys (Q36827361) (← links)
- Animal models in virus research: their utility and limitations (Q38043556) (← links)
- A novel HIV vaccine targeting the protease cleavage sites (Q40047295) (← links)
- Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites. (Q51002244) (← links)
- Frequencies of Circulating Th1-Biased T Follicular Helper Cells in Acute HIV-1 Infection Correlate with the Development of HIV-Specific Antibody Responses and Lower Set Point Viral Load (Q57206379) (← links)